Retinoids in cancer treatment

Area of Science:

• Oncology
• Pharmacology
• Molecular Biology

Background:

• Vitamin A derivatives (retinoids) are crucial for epithelial tissue integrity.
• Retinoids inhibit experimental carcinogenesis, particularly in mammary and urothelial tissues.
• High toxicity of vitamin A spurred the development of safer synthetic retinoids.

Purpose of the Study:

• To explore the chemopreventive and therapeutic potential of retinoids in cancer.
• To investigate the role of retinoids as differentiating agents in cancer therapy.
• To understand the molecular mechanisms linking retinoids to cancer development and treatment.

Main Methods:

• Experimental animal models for chemically induced carcinogenesis.
• Synthesis and testing of over 1500 synthetic retinoid derivatives.
• Clinical studies on retinoids for acute promyelocytic leukemia and other malignancies.
• Molecular analysis of retinoic acid nuclear receptors and chromosomal abnormalities.

Main Results:

• Retinoids effectively inhibit experimental mammary and urothelial carcinogenesis.
• Synthetic retinoids demonstrate chemopreventive potential with reduced toxicity.
• All-trans-retinoic acid induces complete remissions in acute promyelocytic leukemia.
• Specific DNA rearrangements in the retinoic acid nuclear receptor are linked to acute promyelocytic leukemia.

Conclusions:

• Retinoids are effective differentiating agents for cancer prevention and therapy.
• Synthetic retinoids offer a promising therapeutic index for cancer treatment.
• Retinoids may prevent recurrent malignancies, such as head and neck squamous cell carcinoma.
• Further research into retinoid synergism with other agents is warranted for broader applications.